PharmacyCodes



Verladyn en es it fr

Verladyn Brand names, Verladyn Analogs

Verladyn Brand Names Mixture

  • No information avaliable

Verladyn Chemical_Formula

C33H37N5O5

Verladyn RX_link

http://www.rxlist.com/cgi/generic2/dihyergmes.htm

Verladyn fda sheet

Verladyn FDA

Verladyn msds (material safety sheet)

Verladyn MSDS

Verladyn Synthesis Reference

No information avaliable

Verladyn Molecular Weight

583.678 g/mol

Verladyn Melting Point

No information avaliable

Verladyn H2O Solubility

No information avaliable

Verladyn State

Solid

Verladyn LogP

No information avaliable

Verladyn Dosage Forms

Liquid

Verladyn Indication

For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.

Verladyn Pharmacology

Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.

Verladyn Absorption

Interpatient variable and may be dependent on the administration technique

Verladyn side effects and Toxicity

Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting

Verladyn Patient Information

PATIENT INFORMATIOn

Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.

http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm

Verladyn Organisms Affected

Humans and other mammals